Abstract:Background Cancer stem cells (CSCs) possess abilities of self-renewal and differentiation, have oncogenic potential and are regarded to be the source of cancer recurrence. However, the mechanism by which CSCs maintain their stemness remains largely unclear. Methods In this study, the cell line-derived ovarian CSCs (OCSCs), 3AO and Caov3, were enriched in serum-free medium (SFM). Differentially expressed proteins were compared between the OCSC subpopulation and parental cells using liquid chromatography (LC)-mass spectrometry (MS)/MS label-free quantitative proteomics. Sphere-forming ability assays, flow cytometry, quantitative real-time polymerase chain reaction (qPCR ) , western blotting, and in vivo xenograft experiments were performed to evaluate stemness. RNA-sequencing (RNA-seq) and pyrosequencing were used to reveal the mechanism by which STON2 negatively modulates the stem-like properties of ovarian cancer cells. Results Among the 74 most differentially expressed proteins, stonin 2 (STON2) was confirmed to be down-regulated in the OCSC subpopulation. We show that STON2 negatively modulates the stem-like properties of ovarian cancer cells, which are characterized by sphere formation, a CD44 + CD24 − ratio, and by CSC- and epithelial mesenchymal transition (EMT)-related markers. STON2 knockdown also accelerated tumorigenesis in NOD/SCID mice. Further investigation revealed a downstream target, mucin 1 (MUC1), as up-regulated upon the down regulation of STON2. A decrease in both DNA methyltransferase 1 (DNMT1) expression and methylation in the promoter region of MUC1 was associated with subsequently elevated MUC1 expression, as detected in STON2 knockdown in 3AO and Caov3 cells. Direct DNMT1 knockdown simultaneously elevated MUC1 expression. The functional significance of this STON2-DNMT1/MUC1 pathway is supported by the observation that STON2 overexpression suppresses MUC1-induced sphere formation of OCSCs. The paired expression of STON2 and MUC1 in ovarian cancer specimens was also detected revealing the prognostic value of STON2 expression to be highly dependent on MUC1 expression. Conclusions Our results imply that STON2 may negatively regulate stemness in ovarian cancer cells via DNMT1-MUC1 mediated epigenetic modification. STON2 is therefore involved in OCSC biology and may represent a therapeutic target for innovative treatments aimed at ovarian cancer eradication.

Knockdown of Nucleostemin in an Ovarian Cancer SKOV-3 Cell Line and Its Effects on Cell Malignancy

Ovarian Carcinoma Cells Inhibit T Cell Proliferation: Suppression of IL-2 Receptor Β and Γ Expression and Their JAK-STAT Signaling Pathway

SNORD89 Promotes Stemness Phenotype of Ovarian Cancer Cells by Regulating Notch1-c-Myc Pathway

Effects of Dynein Light Chain Tctex-type 3 on the Biological Behavior of Ovarian Cancer

[Ovarian carcinoma cell inhibits T cell JAK-STAT signal transduction pathway, an experimental study].

Downregulation of Hsa_circ_0026123 Suppresses Ovarian Cancer Cell Metastasis and Proliferation Through the Mir‑124‑3p/ezh2 Signaling Pathway.

STON2 Negatively Modulates Stem-Like Properties in Ovarian Cancer Cells Via DNMT1/MUC1 Pathway.

Oncostatin M Promotes Proliferation of Ovarian Cancer Cells Through Signal Transducer and Activator of Transcription 3

Effect of Down-Regulated Transcriptional Repressor ZEB1 on the Epithelial-Mesenchymal Transition of Ovarian Cancer Cells

The Impact of Nucleostemin siRNA on the Proliferation of HepG2 Cells

STK3 Suppresses Ovarian Cancer Progression by Activating NF-κB Signaling to Recruit CD8+ T-Cells

Nucleostemin Regulates Proliferation and Migration of Gastric Cancer and Correlates with Its Malignancy.

Role of Long Non-Coding RNA SNHG1 in Occurrence and Progression of Ovarian Carcinoma.

Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in Ovarian Cancer

Retracted: Nucleostemin Regulates Proliferation and Migration of Gastric Cancer and Correlates with Its Malignancy (retracted Article. See Vol. 10, Pg. 15800, 2017)

Ovarian carcinoma cells inhibit T cell proliferation: suppression of IL-2 receptor beta and gamma expression and their JAK-STAT signaling pathway.

Knock-down Akt 3 inhibits ovarian cancer cell growth and migration

Nucleostemin Promotes the Proliferation of Human Glioma Via Wnt/β‐Catenin Pathway

NUMB Knockdown Enhanced the Anti-Tumor Role of Cisplatin on Ovarian Cancer Cells by Inhibiting Cell Proliferation and Epithelial-Mesenchymal Transition

Expression of Nucleostemin Gene in Epithelial Ovarian Tumor and Its Relation with Clinical Pathology

Expression of DNMT1 in ovarian cancer tissue and its effects on proliferation and migration of ovarian cancer cells